Benitec Biopharma Inc.
BNTC
$14.10
$0.322.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.92M | -26.49M | -21.42M | -20.86M | -21.75M |
| Total Depreciation and Amortization | 396.00K | 369.00K | 353.00K | 352.00K | 343.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.66M | 3.67M | 1.26M | 1.18M | 831.00K |
| Change in Net Operating Assets | -2.73M | 3.79M | -1.95M | -83.00K | 1.17M |
| Cash from Operations | -23.59M | -18.67M | -21.75M | -19.41M | -19.40M |
| Capital Expenditure | -18.00K | -18.00K | -191.00K | -179.00K | -179.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.00K | -18.00K | -191.00K | -179.00K | -179.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 81.87M | 82.57M | 82.57M | 64.73M | 73.96M |
| Repurchase of Common Stock | -9.07M | -9.07M | -39.00K | -39.00K | -39.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.32M | 34.52M | -2.93M | -2.93M | -5.89M |
| Cash from Financing | 70.49M | 108.01M | 79.60M | 61.77M | 68.03M |
| Foreign Exchange rate Adjustments | 49.00K | 164.00K | 300.00K | -146.00K | -8.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.93M | 89.49M | 57.96M | 42.03M | 48.44M |